Media Highlights and Announcements
ausbizFebruary 08, 2022
John Barrington AM talks to ausbiz about the company’s strategy across the US, UK and Europe, and shares insights into the recent December quarter update.
Proactive InvestorsFebruary 05, 2022
John Barrington AM talks to Proactive Investor about the company’s appointment of Dr. Jacque Sokolov as Chair of Artrya’s Clinical Advisory Board.
Artrya Limited (ASX: AYA, Artrya or the Company) is today announcing the appointment of renowned healthcare executive Dr. Jacque J. Sokolov as Chair of Artrya’s Clinical Advisory Board.
Bio WorldNovember 30, 2021
Medtech newcomer Artrya Ltd. listed on the Australian Securities Exchange (ASX) in an AU$40 million (US$28.6 million) initial public offering.
The Motley FoolNovember 29, 2021
Move over Appen, the new AI player in town went gangbusters on its first day as a public company.
November 26, 2021
Fresh from its ASX debut, AYA’s mission is simple: it’s out to more accurately and less invasively detect signs of heart disease with the power of artificial intelligence (AI).
Business NewsNovember 26, 2021
Local medtech Artya has listed on the stock exchange, having earlier raised $40 million through an IPO to help commercialise its cardiac imaging software.
The Market HeraldNovember 26, 2021
Artrya (AYA), an artificial intelligence medical technology business, has started trading on the ASX after the successful completion of its initial public offering (IPO).
StockheadNovember 26, 2021
The medical technology company listed today after raising $40 million at $1.35. Its share price is up ~13% to $1.52.